Khorsandi et al., 2021 - Google Patents
A mechanistic perspective on targeting bacterial drug resistance with nanoparticlesKhorsandi et al., 2021
- Document ID
- 6253972502159678350
- Author
- Khorsandi K
- Keyvani-Ghamsari S
- Khatibi Shahidi F
- Hosseinzadeh R
- Kanwal S
- Publication year
- Publication venue
- Journal of Drug Targeting
External Links
Snippet
Bacterial infections are an important cause of mortality worldwide owing to the prevalence of drug resistant bacteria. Bacteria develop resistance against antimicrobial drugs by several mechanisms such as enzyme inactivation, reduced cell permeability, modifying target site or …
- 239000002105 nanoparticle 0 title abstract description 458
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Munir et al. | Recent advances in nanotechnology-aided materials in combating microbial resistance and functioning as antibiotics substitutes | |
Rabiee et al. | Silver and gold nanoparticles for antimicrobial purposes against multi-drug resistance bacteria | |
Franco et al. | Metal-based nanoparticles: Antibacterial mechanisms and biomedical application | |
Fulaz et al. | Nanoparticle–biofilm interactions: the role of the EPS matrix | |
Khorsandi et al. | A mechanistic perspective on targeting bacterial drug resistance with nanoparticles | |
Vassallo et al. | Nanoparticulate antibiotic systems as antibacterial agents and antibiotic delivery platforms to fight infections | |
Sun et al. | Colorimetric band-aids for point-of-care sensing and treating bacterial infection | |
Choi et al. | Drug delivery strategies for antibiofilm therapy | |
Mao et al. | Local photothermal/photodynamic synergistic therapy by disrupting bacterial membrane to accelerate reactive oxygen species permeation and protein leakage | |
Baptista et al. | Nano-strategies to fight multidrug resistant bacteria—“A Battle of the Titans” | |
Zheng et al. | Mercaptopyrimidine-conjugated gold nanoclusters as nanoantibiotics for combating multidrug-resistant superbugs | |
Mishra et al. | Therapeutic strategies against biofilm infections | |
Gunawan et al. | Nanosilver targets the bacterial cell envelope: the link with generation of reactive oxygen radicals | |
Durán et al. | Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity | |
Mohanta et al. | Nanotechnology in combating biofilm: A smart and promising therapeutic strategy | |
Chen et al. | Metal nanobullets for multidrug resistant bacteria and biofilms | |
Feris et al. | Electrostatic interactions affect nanoparticle-mediated toxicity to gram-negative bacterium Pseudomonas aeruginosa PAO1 | |
Liu et al. | Antimicrobial nanomaterials against biofilms: an alternative strategy | |
Hajipour et al. | Antibacterial properties of nanoparticles | |
Jang et al. | Development of antibiofilm nanocomposites: Ag/Cu bimetallic nanoparticles synthesized on the surface of graphene oxide nanosheets | |
Mateo et al. | Silver nanoparticle-based therapy: can it be useful to combat multi-drug resistant bacteria? | |
Swolana et al. | Activity of silver nanoparticles against Staphylococcus spp. | |
Chavan et al. | Ampicillin-mediated functionalized gold nanoparticles against ampicillin-resistant bacteria: strategy, preparation and interaction studies | |
Jampilek et al. | Advances in nanostructures for antimicrobial therapy | |
Moradi et al. | Recent advance on nanoparticles or nanomaterials with anti-multidrug resistant bacteria and anti-bacterial biofilm properties: A systematic review |